Gut microbiome and symptoms in females with irritable bowel syndrome: a cross-sectional analysis
- 28 May 2024
- journal article
- research article
- Published by Walter de Gruyter GmbH in Beneficial Microbes
- Vol. 15 (3) , 259-273
Abstract
Irritable bowel syndrome (IBS), a disorder of gut-brain interaction, is associated with abdominal pain and stool frequency/character alterations that are linked to changes in microbiome composition. We tested whether taxa differentially abundant between females with IBS vs healthy control females (HC) are associated with daily gastrointestinal and psychological symptom severity. Participants (age 18-50 year) completed a 3-day food record and collected a stool sample during the follicular phase. They also completed a 28-day diary rating symptom intensity; analysis focused on the three days after the stool sample collection. 16S rRNA gene sequencing was used for bacterial identification. Taxon abundance was compared between IBS and HC using zero-inflated quantile analysis (ZINQ). We found that females with IBS (n = 67) had greater Bacteroides abundance (q = 0.003) and lower odds of Bifidobacterium presence (q = 0.036) compared to HC (n = 46) after adjusting for age, race, body mass index, fibre intake, and hormonal contraception use. Intestimonas, Oscillibacter, and Phascolarctobacterium were more often present and Christensenellaceae R-7 group, Collinsella, Coprococcus 2, Moryella, Prevotella 9, Ruminococcaceae UCG-002, Ruminococcaceae UCG-005, and Ruminococcaceae UCG-014 were less commonly present in IBS compared to HC. Despite multiple taxon differences in IBS vs HC, we found no significant associations between taxon presence or abundance and average daily symptom severity within the IBS group. This may indicate the need to account for interactions between microbiome, dietary intake, metabolites, and host factors.Keywords
Funding Information
- National Institute of Nursing Research (NR013497)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK56338)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK130517)
- National Institutes of Health (R01 AI10091401)
- National Institutes of Health (P01 AI152999)
- National Institutes of Health (U01 AI24290)
- National Institute of Nursing Research (K23NR020044)
This publication has 46 references indexed in Scilit:
- Differences in gut microbiota associated with stress resilience and susceptibility to single prolonged stress in female rodentsNeurobiology of Stress, 2023
- Longitudinal Multi-omics Reveals Subset-Specific Mechanisms Underlying Irritable Bowel SyndromeCell, 2020
- Feeling down? A systematic review of the gut microbiota in anxiety/depression and irritable bowel syndromeJournal of Affective Disorders, 2020
- Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control StudiesJournal of the Academy of Nutrition and Dietetics, 2020
- Microbiome and Its Role in Irritable Bowel SyndromeDigestive Diseases and Sciences, 2020
- The Effect of Bifidobacterium on Reducing Symptomatic Abdominal Pain in Patients with Irritable Bowel Syndrome: A Systematic ReviewProbiotics and Antimicrobial Proteins, 2019
- Similarly in depression, nuances of gut microbiota: Evidences from a shotgun metagenomics sequencing study on major depressive disorder versus bipolar disorder with current major depressive episode patientsJournal of Psychiatric Research, 2019
- Intestinal microbiome-gut-brain axis and irritable bowel syndromeWiener Medizinische Wochenschrift, 2017
- Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysisDigestive and Liver Disease, 2017
- Testing in Microbiome-Profiling Studies with MiRKAT, the Microbiome Regression-Based Kernel Association TestThe American Journal of Human Genetics, 2015